Sylvie Luria

CEOD, Technology Transfer Company, Tel Hashomer Medical Research, Infrastructure and Services Ltd.

Dr. Luria received her PhD from the Weizmann Institute of Science, did her Post Doctorate at Stanford Medical School, and served as a visiting scientist at the Massachusetts Institute of Technology.

Dr. Luria has a unique combination of life science education, extensive research in cellular, molecular, genetic, immunology and virology fields coupled with extensive management and business experience in biomedical start-up companies.

 

From 1999 to 2018, Dr. Luria has been involved in the establishment of more than 42 biomedical startup companies that raised over 220 Million USD in their seed stage.
Dr. Luria serves as a director in 12 companies.

Dr Luria has expertise in fund-raising and fostering strategic partnerships with pharmaceutical and biotechnology companies worldwide and has demonstrated capabilities in developing biological products for the BioMedical companies.

Dr. Luria has comprehensive experience in biomedical technology assessment, due diligence, technical representation with strategic planning, management and development of biotechnology companies.

From 1999 to 2015, Dr. Luria has been involved in the establishment of more than 40 biomedical startup companies that raised over 260 Million USD in their seed stage.

From 2007 to Present – Dr. Luria serves as the Sheba Medical Center Technology Transfer Company CEO •Raising Research Funds from Industrial resources to enhance Sheba's patent portfolio •Commercialization of over 55% of the Sheba's IP portfolio - identification of potential partners, commercial and legal negotiation, preparing and executing licensing agreements with third parties.

  • Managing Licensing Agreements and Inter Institutional Agreements.
  • Board Member in Sheba's company spinoffs.